Results 231 to 240 of about 60,295 (249)

Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial

Lancet, The, 2020
Michelle S Hsiang, Kathryn W Roberts, Munyaradzi Tambo   +2 more
exaly  

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Lancet, The, 2014
Philip C Buttery, Philippe Le Corvoisier, David P Breen   +2 more
exaly  

Ultrafast vector imaging of plasmonic skyrmion dynamics with deep subwavelength resolution

Science, 2020
Timothy Davis, David Janoschka, Pascal Dreher   +2 more
exaly  

Learning Vector Quantization

2011
openaire   +1 more source

Improving Learning Vector Quantization

2006
C. D'ELIA, C. DE STEFANO, MARCELLI, Angelo, A. SCOTTO DI FRECA   +3 more
openaire   +1 more source

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

Science, 2009
Kejin Hu, Shulan Tian, Igor I Slukvin
exaly  

EEG Classification by Learning Vector Quantization - EEG-Klassifikation mit Hilfe eines Learning Vector Quantizers

Biomedizinische Technik/Biomedical Engineering, 1992
D. Flotzinger, J. Kalcher, G. Pfurtscheller   +2 more
openaire   +1 more source

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2017
Qiang Guo, Zhe Zhang, Wei Chen
exaly  

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

Lancet, The, 2004
Kimberly C Gilmour, Christof von Kalle, Torben Barington   +2 more
exaly  

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

Lancet, The, 2015
Pei Liu, Wei Chen
exaly